Seize an uncommon opportunity and join our growing EU-based team. We are looking to hire several Rare Disease Managers in Germany. Learn more:?https://lnkd.in/gjNt2Bwh
关于我们
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers.
- 网站
-
https://www.springworkstx.com
SpringWorks Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Stamford,Connecticut
- 类型
- 上市公司
- 创立
- 2017
地点
SpringWorks Therapeutics员工
动态
-
We are proud to sponsor the ESMO - European Society for Medical Oncology Sarcoma and Rare Cancers Congress in Lugano, Switzerland. We look forward to meeting with other individuals and organizations who are committed to advancing care and improving outcomes for patients with sarcomas and rare cancers.?#ESMORareCancers25
-
-
Desmoid tumors are rare, aggressive and locally invasive soft tissue tumors that may cause different symptoms that can affect the daily lives of patients. Since symptoms can differ for each person depending on the location of the tumor, trying to learn about the condition can be confusing.? ?? Hear from Jennifer Fisher, jewelry designer and patient advocate. She talks about her diagnosis journey, the importance of taking action and speaking with a specialist, like an oncologist with experience treating desmoid tumors, about available treatments, including non-surgical options.? ?? Hear Jennifer’s full story of resilience: https://lnkd.in/gBXpGUnR?
-
-
Bringing the first FDA-approved therapy to patients with #DesmoidTumors was a story of tenacity, persistence and collaboration. SpringWorks is honored to be serving the desmoid tumor community and is grateful to our collaborators that helped make this milestone happen.
Take a moment to read the newly published article, "Nirogacestat—the pathway to approval of the first treatment for desmoid tumors, a rare disease," which chronicles the clinical development journey of nirogacestat from 2009 to November 2023. ?? Read the full article: https://lnkd.in/edMCNntb ? For roughly fifteen years, the DTRF advocated for this groundbreaking treatment in close collaboration with patients, clinical advisors and key stakeholders, including SpringWorks Therapeutics . DTRF offers a heartfelt thank you to all stakeholders who contributed to this important milestone. #desmoidtumorawareness #DTRF #DesmoidTumorResearchFoundation #Desmoidian #DesmoidTumors #desmoidtumor #desmoidresearch #aggressivefibromatosis #FAP #OrphanDisease #raredisease
-
-
Yesterday, Jennifer Fisher, jewelry designer and #DesmoidTumor patient advocate, appeared on Good Day New York to talk with Rosanna Scotto about her rare disease journey.?? ? If you missed the live interview, you can watch it below to learn more about Jennifer’s desmoid tumor story.?
-
Jennifer Fisher, jewelry designer and #DesmoidTumor patient advocate, joined Rosanna Scotto from Fox 5 (WNYW-TV New York) on Good Day New York this morning to share her journey living with a desmoid tumor and to highlight available treatments, including non-surgical treatment options. ? ? Hear Jennifer’s desmoid tumor story: https://lnkd.in/gUYRRxUS
-
-
We are excited to be at the German Sarcoma Conference. Attendees can visit our booth to learn more about our company and who we are.?? ? #SarcomaCare?
-
-
In recognition of International Women’s Day, our Women+ Initiative Network employee resource group will host a panel discussion in conjunction with the HBA’s RTP Chapter, which will be moderated by our very own, Elizabeth Dare, and feature Gayle Flynn from Cognizant and Deidra Hudson from Apellis Pharmaceuticals. The panelists share what it means to #AccelerateAction for women's advancement.? ? #IWD2025?
-
We are proud that #SpringWorkers are passionate about what they do and work with urgency on behalf of patients with devastating rare diseases. This #EmployeeAppreciationDay, we asked our Chief People Officer, Daniel J. Pichl, what he admires most about the SpringWorks team.?
-
We're excited to share the latest podcast episode from Progress, Potential, And Possibilities, featuring sarcoma specialist, Dr. Alessandra Maleddu. Dr. Maleddu discusses the unique challenges of diagnosing and treating desmoid tumors, which are rare and locally aggressive tumors. She also highlights the importance of finding a physician with experience treating desmoid tumors to get an accurate diagnosis, the challenges of re-occurrence with surgery and the significant impact of desmoid tumors on patients' lives.?? ? Watch the full episode: https://lnkd.in/e5-XatNA??
Dr. Alessandra Maleddu, MD - University of Colorado Cancer Center - Decoding Desmoid Tumors
https://www.youtube.com/